We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Studies in Haemolytic Streptococcus Fibrinolysin, Antifibrinolysin and Antistreptolysin, with Particular Reference to Rheumatic Fever

JAMA. 1941;117(23):2015. doi:10.1001/jama.1941.02820490089038.
Text Size: A A A
Published online


This monograph contains a detailed and careful review of classification and antigenic properties of the streptococci, and numerous personal observations on fibrinolysis, antifibrinolysis and antistreptolysis. The work was carried out at the University of Lund, Sweden, from which other authors, connected with Dr. Winblad, have presented important contributions to the study of rheumatic fever. Therefore especial attention is directed to the significance of variations in titer of antifibrinolysin and antistreptolysin for the etiologic problem of rheumatic fever. In rheumatic fever the titer of both these antibodies rises to the level observed in other streptococcic diseases. The titer rises during the first weeks of the disease even if no accompanying or preceding streptococcic infection can be traced, and it slowly returns to normal, though it remains elevated longer than the sedimentation rate. In the interpretation of his data the author asks himself whether the occurrence of an elevated antibody titer against


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.